These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 15370103

  • 1. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V, Kobzar G, Samel N.
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [Abstract] [Full Text] [Related]

  • 2. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY, Chirkova LP, Sage RE, Horowitz JD.
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [Abstract] [Full Text] [Related]

  • 3. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG, Wong T, Frojmovic MM.
    Thromb Haemost; 1988 Apr 08; 59(2):323-8. PubMed ID: 2455359
    [Abstract] [Full Text] [Related]

  • 4. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V, Stemerman M, Schafer A, Adelman B, Smith M, Fuhro R, Salzman E.
    J Lab Clin Med; 1985 Nov 08; 106(5):551-61. PubMed ID: 2997353
    [Abstract] [Full Text] [Related]

  • 5. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
    Stürzebecher S, Nieuweboer B, Matthes S, Schillinger E.
    Prog Clin Biol Res; 1989 Nov 08; 301():365-9. PubMed ID: 2477855
    [No Abstract] [Full Text] [Related]

  • 6. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M, Kazama T, Ikeda T, Sato S.
    Platelets; 2000 Dec 08; 11(8):446-58. PubMed ID: 11177444
    [Abstract] [Full Text] [Related]

  • 7. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
    Beretz A, Stierle A, Anton R, Cazenave JP.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3597-600. PubMed ID: 6295405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
    Fisher CA, Kappa JR, Sinha AK, Cottrell ED, Reiser HJ, Addonizio VP.
    J Lab Clin Med; 1987 Feb 15; 109(2):184-90. PubMed ID: 2433373
    [Abstract] [Full Text] [Related]

  • 10. Exhibition of anti-platelet effect of isocarbacyclin methyl ester and its free acid via an increase in cAMP in platelets.
    Aoki Y, Inoue K, Kitahara S, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep 15; 45(9):970-4. PubMed ID: 7488315
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P, Colli S, Sirtori C, Tremoli E, Paoletti R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Sep 15; 13():363-9. PubMed ID: 2408447
    [Abstract] [Full Text] [Related]

  • 13. PGI2 and PGE1 induce morphological alterations in human platelets similar to those of the initial phase of activation.
    Zilla P, Groscurth P, Varga G, Fischlein T, Fasol R.
    Exp Hematol; 1987 Aug 15; 15(7):741-9. PubMed ID: 3301381
    [Abstract] [Full Text] [Related]

  • 14. Anti-platelet effects of isocarbacyclin methyl ester on human and rabbit platelets in vitro.
    Inoue K, Aoki Y, Kitahara S, Kiyoki M, Araki H.
    Arzneimittelforschung; 1995 Sep 15; 45(9):975-9. PubMed ID: 7488316
    [Abstract] [Full Text] [Related]

  • 15. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A, Cerletti C, de Gaetano G.
    Thromb Haemost; 2006 Dec 15; 96(6):767-73. PubMed ID: 17139371
    [Abstract] [Full Text] [Related]

  • 16. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW, Stuart RK.
    J Lab Clin Med; 1974 Jul 15; 84(1):111-21. PubMed ID: 4365532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU, Just M, Schlotte V, Seiffge D.
    Vasa; 1989 Jul 15; 18(4):273-6. PubMed ID: 2514520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.